ExecPay

Aimmune Therapeutics

  • Pharmaceutical Preparations
  • Brisbane, California

Compensation history

Top executives at Aimmune Therapeutics received an average of $2M per person in annual compensation from 2014 to 2019.

Average pay of disclosed executives at Aimmune Therapeutics
2014201520162017201820190900K1.8M2.7M3.6M
  • Salary
  • Stock
  • Options
  • Non-Equity Incentive
  • Bonus
  • Other

By year

Executives

We found ten executives who work or worked at Aimmune Therapeutics.

Jayson Dallas

Aimmune Therapeutics

Chief Executive Officer

2

Eric Bjerkholt

Aimmune Therapeutics

Chief Financial Officer

3

Daniel Adelman

Aimmune Therapeutics

Chief Medical Officer

4

Andrew Oxtoby

Aimmune Therapeutics

Chief Commercial Officer

1

Douglas Sheehy

Aimmune Therapeutics

General Counsel

3

Stephen Dilly

Aimmune Therapeutics

Chief Executive Officer

5

Susan Barrowcliffe

Aimmune Therapeutics

General Manager, Europe

1

Jeffrey Knapp

Aimmune Therapeutics

Chief Operating Officer

2

News

About Aimmune Therapeutics

  • Industry classifications
  • Division
    Manufacturing
    • Major group
      Chemicals And Allied Products
      • Industry group
        Drugs
        • Industry
          Pharmaceutical Preparations
  • Address
    8000 Marina Boulevard, Suite 300, Brisbane, California 94005-1884
  • Phone
    (650) 614-5220
  • Fiscal year end
    December 31
  • Former names
  • Allergen Research Corp
    Until March 24, 2015
Source: SEC filings on April 9, 2020, April 10, 2019, April 11, 2018, and April 12, 2016.
0